MedPath

NORFLEX

NORFLEX

Discontinued
DIN Number

01966162

Drug Class

Human

Market Date

Dec 31, 1961

Company
HC

valeant canada lp / valeant canada s.e.c.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01966162
AIG Number0102078002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
M03BC01 ORPHENADRINE (CITRATE)
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification12:20.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ORPHENADRINE CITRATEActive
Strength: 30 MG / ML
Monograph: ORPHENADRINE CITRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.